Anzalone Christopher Richard bought ARWR

March 3, 2025 · Form 4 insider transaction

Anzalone Christopher Richard bought 166,667 shares of Arrowhead Pharmaceuticals, Inc. at $7.75 per share, a transaction worth $1.29M. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 2 days after the transaction.